MSB 2.58% 94.5¢ mesoblast limited

Silviu Itescu The Legend, page-300

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    I’d say you must be right.

    The FDA were so impressed with the results they were in a state of shock and ticked the ‘approval rejected’ box instead of the “approved” box on msb’s application form.

    Big pharma (loads of them) are also in a stupor and despite being shopped around the traps, no one wants to even partner let alone buy the IP over the course of many years.

    I mean, here we are, with all these applications for an alleged paradigm advancement in medical treatment for a wide range of conditions but no one will touch the product.

    Simply bizarre. I don’t understand that. When it’s fairly routine for promising treatments to be snapped up by big pharma well before final approvals… sometimes quite early in the development.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.